(19)
(11) EP 4 739 145 A1

(12)

(43) Date of publication:
13.05.2026 Bulletin 2026/20

(21) Application number: 24739531.2

(22) Date of filing: 03.07.2024
(51) International Patent Classification (IPC): 
A23L 29/231(2016.01)
A61K 31/732(2006.01)
A61P 1/00(2006.01)
C12Q 1/00(2006.01)
A23L 33/135(2016.01)
A61K 35/74(2015.01)
C12N 1/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 35/74; A61K 31/732; A23L 29/231; A23L 33/135; A61P 1/00; A23L 33/21; C12N 1/20; C12R 2001/01; G01N 33/56911; A61K 31/736; A61K 31/718; A61K 31/717; A61K 36/06
 
C-Sets:
  1. A61K 31/717, A61K 2300/00;
  2. A61K 36/06, A61K 2300/00;
  3. A61K 31/732, A61K 2300/00;
  4. A61K 35/74, A61K 2300/00;
  5. A61K 31/736, A61K 2300/00;
  6. A61K 31/718, A61K 2300/00;

(86) International application number:
PCT/EP2024/068780
(87) International publication number:
WO 2025/008427 (09.01.2025 Gazette 2025/02)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 04.07.2023 EP 23183452

(71) Applicant: PharmaBiome AG
8952 Schlieren (CH)

(72) Inventors:
  • LEVENTHAL, Gabriel
    4148 Pfeffingen (CH)
  • DE WOUTERS, Tomas
    8047 Zürich (CH)
  • THABUIS, Clémentine
    62136 Lestrem (FR)

(74) Representative: Cabinet Becker et Associés 
25, rue Louis le Grand
75002 Paris
75002 Paris (FR)

   


(54) METHOD FOR ESTABLISHING A COMBINATION THERAPY AND CORRESPONDING PHARMACEUTICAL AND NUTRITIONAL COMBINATIONS